These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Resistance to antitubercular agents in mycobacterial infections in HIV-positive patients]. Dal Conte I, Quirino T, Orlando G, Infuso A, Tocalli L, Dedivitis G, Argenteri B. G Ital Chemioter; 1991; 38(1-3):195-6. PubMed ID: 1365591 [No Abstract] [Full Text] [Related]
23. Use of thiacetazone. Wilkinson D, Moore D. Lancet; 1995 Jan 07; 345(8941):63. PubMed ID: 7528313 [No Abstract] [Full Text] [Related]
24. Coexistence of fixed drug eruptions and Stevens Johnson syndrome due to thiacetazone in a patient of pulmonary tuberculosis. Gupta PK, Luniya AK, Gupta NK, Tiwari ML. Indian J Chest Dis Allied Sci; 1983 Jan 07; 25(2):152-4. PubMed ID: 6197367 [No Abstract] [Full Text] [Related]
32. Thiacetazone skin reaction in Papua New Guinea. Naraqi S, Temu P. Med J Aust; 1980 May 17; 1(10):480-1. PubMed ID: 6157976 [Abstract] [Full Text] [Related]
33. [A case report: septicemia caused by Mycobacterium tuberculosis in a patient infected with the human immunodeficiency virus in Burundi]. Kamamfu G, Nikoyagize E, Ndayiragije A, Cishako A, Aubry P. Bull Soc Pathol Exot; 1991 May 17; 84(4):362-4. PubMed ID: 1807851 [Abstract] [Full Text] [Related]
37. Treatment of tuberculosis in developing countries. van Bogaert LJ. Lancet; 1995 Oct 21; 346(8982):1099-100. PubMed ID: 7564807 [No Abstract] [Full Text] [Related]
38. Combining TB treatment with HIV testing and treatment could save lives of up to 500,000 HIV-positive Africans every year. Indian J Med Sci; 2004 Sep 21; 58(9):407-9. PubMed ID: 15902775 [No Abstract] [Full Text] [Related]